IH - iHuman Inc. Stock Analysis | Stock Taper
Logo
iHuman Inc.

IH

iHuman Inc. NYSE
$1.73 -3.89% (-0.07)

Market Cap $17.87 M
52w High $3.60
52w Low $1.67
Dividend Yield 4.34%
Frequency Annual
P/E 6.18
Volume 1.25K
Outstanding Shares 10.33M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $204.69M $123.31M $21.47M 10.49% $2.1 $16.58M
Q2-2025 $200.16M $116.26M $31.89M 15.93% $3.1 $19.49M
Q1-2025 $210.44M $122.18M $26.52M 12.6% $2.55 $21.6M
Q4-2024 $232.68M $141.52M $26.48M 11.38% $2.55 $14.92M
Q3-2024 $239.41M $143.17M $25.14M 10.5% $2.4 $20.7M

What's going well?

Revenue and gross profit are both up, showing the company is still growing. Margins remain high, and there is no debt burden. The business is still profitable overall.

What's concerning?

Operating expenses are rising much faster than sales, squeezing profits. Net income and earnings per share dropped sharply, and efficiency is slipping. If costs keep rising, future profits could be at risk.

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $1.13B $1.37B $384.8M $983.48M
Q2-2025 $1.1B $1.34B $365.7M $969.39M
Q1-2025 $1.12B $1.37B $431.15M $941.04M
Q4-2024 $1.17B $1.42B $458.8M $960.85M
Q3-2024 $1.17B $1.42B $494.31M $926.33M

What's financially strong about this company?

IH has over $1.1 billion in cash and investments, very little debt, and more than enough assets to cover all liabilities. The company is growing its equity and buying back shares, showing confidence in its future.

What are the financial risks or weaknesses?

Receivables and payables are both rising, which could signal slower customer payments or delayed supplier payments. Deferred revenue dipped, so watch for any slowdown in customer prepayments.

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q2-2025 $31.89M $0 $0 $0 $0 $0
Q1-2025 $26.52M $0 $0 $0 $0 $0
Q4-2024 $26.48M $0 $0 $0 $0 $0
Q3-2024 $25.14M $0 $0 $0 $0 $0
Q2-2024 $24.66M $0 $0 $0 $0 $0

Q1 2021 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at iHuman Inc.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

Core strengths include a robust, cash-rich balance sheet with minimal debt, consistently high gross margins that reflect attractive economics, and a proven ability to move from losses to solid profitability. On the strategic side, iHuman benefits from a differentiated AI-driven product ecosystem, strong brand associations in early-childhood education, diversified revenue channels across consumers and institutions, and deep partnerships that enhance both content quality and distribution reach.

! Risks

Key risks center on the recent deterioration in financial momentum and the challenging industry environment. Revenue and profits have stepped down from their peaks, and operating and free cash flow have weakened sharply, suggesting more fragile underlying performance than earlier years implied. The restart of dividends against this backdrop may constrain flexibility if cash flows do not recover. In addition, regulatory risk in education, intense competition, and execution challenges in overseas expansion and older age segments all add uncertainty.

Outlook

Looking ahead, iHuman appears financially secure and strategically well-positioned, but with a more mixed near-term performance profile. The company has the resources and technological capabilities to pursue growth and deepen its competitive moat, yet it must demonstrate that it can re-stabilize growth, protect margins, and rebuild stronger, more consistent cash generation. The trajectory of international initiatives, user engagement across age groups, and the balance between innovation spending and profitability will largely shape its medium-term prospects.